New patent for Glaxosmithkline Llc drug LAMICTAL ODT

August 17, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for LAMICTAL+ODT Lamictal Odt is a drug marketed by Glaxosmithkline Llc and is included in one NDA. It is available from one supplier. There are three…

The post New patent for Glaxosmithkline Llc drug LAMICTAL ODT appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.